All good, I can change my statement to BMT-CTN will cover most of the trial costs.
Mesoblast will only pay 6-9mil for their share of the Adult aGHVD trial.
Peanuts for Mesoblast's share of costs to achieve a full trial and plenty of money still left in the bank after 6 to 9 mil cost.
I agree with you that Si believes there is also more cash coming in soonish - next 6 months from some type partnership/commercial sales transaction(s). Bring that on.
Si did seem to have a lot of confidence today on the company progression and achievements of these trials completing.
All good, I can change my statement to BMT-CTN will cover most...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.055(4.89%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.06 | $8.816M | 8.055M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 280000 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |